A detailed history of Ostrum Asset Management transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Ostrum Asset Management holds 4,403 shares of ALNY stock, worth $1.08 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,403
Previous 5,742 23.32%
Holding current value
$1.08 Million
Previous $1.4 Billion 13.21%
% of portfolio
0.1%
Previous 0.12%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$233.81 - $287.01 $313,071 - $384,306
-1,339 Reduced 23.32%
4,403 $1.21 Billion
Q2 2024

Aug 13, 2024

SELL
$143.31 - $247.0 $64,059 - $110,409
-447 Reduced 7.22%
5,742 $1.4 Billion
Q4 2023

Feb 13, 2024

BUY
$151.41 - $196.57 $868,184 - $1.13 Million
5,734 Added 1260.22%
6,189 $1.18 Billion
Q3 2023

Nov 14, 2023

SELL
$170.77 - $211.65 $683 - $846
-4 Reduced 0.87%
455 $80.6 Million
Q2 2023

Aug 11, 2023

BUY
$185.01 - $212.05 $185 - $212
1 Added 0.22%
459 $87.2 Million
Q1 2023

May 12, 2023

BUY
$182.66 - $235.53 $83,658 - $107,872
458 New
458 $91.7 Million
Q1 2019

May 15, 2019

SELL
$72.76 - $93.45 $306,974 - $394,265
-4,219 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$62.67 - $88.33 $264,404 - $372,664
4,219 New
4,219 $308,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.